|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM221029168 |
003 |
DE-627 |
005 |
20231224050837.0 |
007 |
tu |
008 |
231224s2011 xx ||||| 00| ||eng c |
028 |
5 |
2 |
|a pubmed24n0736.xml
|
035 |
|
|
|a (DE-627)NLM221029168
|
035 |
|
|
|a (NLM)22977933
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
245 |
1 |
0 |
|a Dabigatran (Pradaxa). An alternative to warfarin (Coumadin) is approved to help treat patients with atrial fibrillation
|
264 |
|
1 |
|c 2011
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
500 |
|
|
|a Date Completed 11.10.2012
|
500 |
|
|
|a Date Revised 21.10.2016
|
500 |
|
|
|a published: Print
|
500 |
|
|
|a Citation Status MEDLINE
|
650 |
|
4 |
|a Journal Article
|
650 |
|
7 |
|a Anticoagulants
|2 NLM
|
650 |
|
7 |
|a Benzimidazoles
|2 NLM
|
650 |
|
7 |
|a Pyridines
|2 NLM
|
650 |
|
7 |
|a Warfarin
|2 NLM
|
650 |
|
7 |
|a 5Q7ZVV76EI
|2 NLM
|
650 |
|
7 |
|a Dabigatran
|2 NLM
|
650 |
|
7 |
|a I0VM4M70GC
|2 NLM
|
773 |
0 |
8 |
|i Enthalten in
|t Heart advisor
|d 1999
|g 14(2011), 4 vom: 13. Apr., Seite 6
|w (DE-627)NLM098274252
|x 1523-9004
|7 nnns
|
773 |
1 |
8 |
|g volume:14
|g year:2011
|g number:4
|g day:13
|g month:04
|g pages:6
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 14
|j 2011
|e 4
|b 13
|c 04
|h 6
|